-
2023
-
Seagen’s Adcetris Gains Expanded Label for Pediatric Cancer Patients
-
How high blood sugar REALLY causes type 2 diabetes: Chemicals produced when glucose is broken down are to blame, study finds
-
AbbVie Reaches $54.4 Million Settlement Over Its Alzheimer’s Drug
-
Walmart Enters Settlement Agreement Over Opioid Lawsuits, Joining CVS and Walgreens
-
CANbridge Pharmaceuticals Granted Orphan Drug Designation for CAN 106 for the Treatment of Myasthenia Gravis
-
Vistagen Announces Publication in Cells Demonstrating AV-101’s Potential for Treating Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease
-
FDA May Approve Naloxone for Nonprescription Use
-
FDA panel backs Ardelyx CKD drug, despite agency concerns
-
Novel AI blood test detects liver cancer
-
Camber Pharmaceuticals Launches Generic Lamictal XR